CLINTON HEALTH ACCESS INITIATIVE INC

EIN: 271414646 501(c)(3) International Affairs

BOSTON, MA

Total Revenue
$224,653,300
Total Expenses
$225,603,286
Total Assets
$160,736,489
Net Assets
$11,026,839
🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Sign In — Free (10 views/day)

Financial Trends

Organization Details

Formation Year
2009
Legal Domicile
AR
Principal Officer
DR NEIL SHAH
Phone
6177740110
Tax Period
2023-01-01 to 2023-12-31

CLINTON HEALTH ACCESS INITIATIVE INC, founded in 2009, is a major nonprofit in the International Affairs sector that reported $224.7M in total revenue in fiscal year 2023.

Mission

FOR 20 YEARS, CHAI'S MISSION HAS BEEN TO SAVE LIVES AND IMPROVE HEALTH OUTCOMES IN LOW-AND MIDDLE-INCOME COUNTRIES AROUND THE WORLD. WE DO THIS BY ENABLING THE GOVERNMENT AND PRIVATE SECTOR TO STRENGTHEN AND SUSTAIN QUALITY HEALTH SYSTEMS.

Program Service Accomplishments

Program 1
Expenses: $112,926,895

OUR PROGRAMS AIM TO SAVE LIVES AND REDUCE THE BURDEN OF DISEASE, WHILE HELPING GOVERNMENTS CREATE SUSTAINABLE HEALTH SYSTEMS. WE OPERATE IN OVER 35 COUNTRIES AND SUPPORT MORE THAN 20 DIFFERENT HEALTH...

Read more

OUR PROGRAMS AIM TO SAVE LIVES AND REDUCE THE BURDEN OF DISEASE, WHILE HELPING GOVERNMENTS CREATE SUSTAINABLE HEALTH SYSTEMS. WE OPERATE IN OVER 35 COUNTRIES AND SUPPORT MORE THAN 20 DIFFERENT HEALTH PROGRAMS. THE VAST MAJORITY OF OUR STAFF ARE LOCATED IN THE COUNTRIES WHERE WE WORK, OVERSEEING IMPLEMENTATION AND MANAGING RELATIONSHIPS WITH PARTNER GOVERNMENTS. THE TEAMS ON THE GROUND ARE COMPLEMENTED BY A GLOBAL TEAM OF SCIENCE, BUSINESS, AND TECHNICAL EXPERTS SUPPORTING THE ENTIRE ORGANIZATION AND BY MANAGEMENT, FINANCE, AND HUMAN RESOURCE TEAMS. INFECTIOUS DISEASES: SEE SCHEDULE O FOR CONTINUATIONINFECTIOUS DISEASES: FOR YEARS, FOUR INFECTIOUS DISEASES DROVE MOST ILLNESS AND DEATH WORLDWIDE: HIV, HEPATITIS, TUBERCUOSIS (TB), AND MALARIA. IN 2020, A NEW ILLNESS, COVID-19, WAS ADDED TO THIS LIST.EARLY ON, THE PANDEMIC BROUGHT MANY HEALTH SYSTEMS TO THEIR KNEES, AND IT CONTINUES TO EXPOSE AND EXACERBATE INEQUITIES THAT ALREADY EXISTED BETWEEN COUNTRIES, PEOPLE, AND ACCESS TO BASIC HEALTH SERVICES. IN 2023, CHAI CONTINUED TO SUPPORT COUNTRIES' LONGTERM RESPONSE TO COVID-19 AND STRENGTHEN HEALTH SYSTEM RESLIENCE TO PREPARE FOR FUTURE PANDEMICS.A CORE COMPONENT OF THIS WORK HAS BEEN STRENGTHENING ACCESS TO MEDICAL OXYGEN IN HEALTHCARE FACILITIES AND HOSPITALS IN LOW- AND MIDDLE-INCOME COUNTRIES THROUGH UPDATING INFRASTRUCTURE (I.E. BUILDING PRESSURE SWING ADSORPTION (PSA) PLANTS; SUPPORTING BEDSIDE DELIVERY OF LIQUID OXYGEN), KEEP OXYGEN EQUIPMENT UP AND RUNNING FOR ITS FULL LIFESPAN AND PROVIDING HEALTH WORKERS WITH THE RIGHT TOOLS, PROCESSES, AND PRACTICES TO SAVE LIVES.AT THE SAME TIME WE CONTINUE TO WORK ON THE DISEASE AREAS THAT WE HAVE FOCUSED ON FOR DECADES, INCLUDING HIV AND ADVANCED HIV DISEASE.FOR EXAMPLE, OUR WORK TO INTRODUCE AFFORDABLE, MORE PALATABLE HIV TREATMENTS FOR CHILDREN. THERE HAVE BEEN VAST IMPROVEMENTS IN PEDIATRIC HIV TREATMENT IN RECENT YEARS, INCLUDING THE RAPID DEVELOPMENT AND INTRODUCTION OF GENERIC PEDIATRIC DOLUTEGRAVIR TABLETS, WHICH DISSOLVE IN WATER AND TASTE LIKE STRAWBERRIES, DRAMATICALLY INCREASING CHILDREN'S ADHERENCE TO THEIR TREATMENT REGIMEN. CHAI IS WORKING WITH PARTNERS TO DRIVE THE DEVELOPMENT AND INTRODUCTION OF MORE GENERIC VERSIONS OF BEST-IN-CLASS CHILDREN'S MEDICATIONS.

Program 2
Expenses: $30,233,497

WOMEN & CHILDREN'S HEALTH: SEE SCHEDULE O FOR CONTINUATIONWOMEN & CHILDREN'S HEALTH: WOMEN AND CHILDREN SUFFER THE GREATEST BURDEN FROM DISEASE GLOBALLY. CHAI HAS SIGNIFICANTLY INCREASED ACCESS TO...

Read more

WOMEN & CHILDREN'S HEALTH: SEE SCHEDULE O FOR CONTINUATIONWOMEN & CHILDREN'S HEALTH: WOMEN AND CHILDREN SUFFER THE GREATEST BURDEN FROM DISEASE GLOBALLY. CHAI HAS SIGNIFICANTLY INCREASED ACCESS TO RECOMMENDED TREATMENTS FOR DIARRHEA AND PNEUMONIA, THE LARGEST KILLERS OF CHILDREN UNDER FIVE; MADE CRITICAL VACCINES THAT PROTECT AGAINST CHILDHOOD ILLNESSES MORE AFFORDABLE; IS COMBATTING CHRONIC MALNUTRITION; AND IS DRAMATIALLY AND SUSTAINABLY REDUCING MATERNAL AND NEWBORN DEATHS AND ENSURING WOMEN HAVE ACCESS TO THE TOOLS THEY NEED TO SAFELY PLAN THER FAMILIES TO IMPROVE HEALTH OUTCOMES AND ECONOMIC WELLBEING.FOR EXAMPLE, WHEN CHAI BEGAN OUR DIARRHEA PROGRAM IN 2012, ONLY ONE-THIRD OF CHILDREN THAT NEEDED LIFESAVING ORAL REHYDRATION SOLUTIONS (ORS) RECEIVED IT. ZINC USAGE RATES WERE EVEN WORSE. THROUGH CHAI'S MARKET SHAPING WORK, WE HELPED REDUCE THE AVERAGE COST OF ZINC/ORS TREATMENT BY 42 PERCENT. WORKING WITH PARTNERS IN INDIA, KENYA, NIGERIA, AND UGANDA, WE ALSO INCREASED THE PERCENTAGE OF CHILDREN WITH DIARRHEA RECEIVING ZINC/ORS FROM LESS THAN ONE PERCENT TO 24 PERCENT.ANOTHER STRONG EXAMPLE IS CHAI'S WORK TO SAVE THE LIVES OF WOMEN AND NEWBORNS. CHAI HAS DEVELOPED AN INTEGRATED MATERNAL, NEWBORN, AND REPRODUCTIVE HEALTH STRATEGY THAT HAS CONTRIBUTED TO SUSTAINED AND SIGNFICANT REDUCTIONS IN DEATH IN COUNTRIES WHERE WE WORK. THIS APPROACH WAS FIRST PILOTED IN ETHIOPIA, BEFORE BEING TESTED AT SCALE IN NIGERIA, WHERE WE SAW A NEARLY 40 PERCENT REDUCTION IN MATERNAL MORTALITY AND A 43 PERCENT REDUCTION IN NEWBORN DEATHS IN A 12- MONTH PERIOD IN TARGET STATES OF NORTHERN NIGERIA. THE PROGRAM HAS BEEN ROLLED OUT MORE RECENTLY IN ZAMBIA AND UGANDA WITH SIMILAR RESULTS.

Program 3
Expenses: $31,790,496

NON-COMMUNICABLE DISEASES: SEE SCHEDULE O FOR CONTINUATIONNON-COMMUNICABLE DISEASES (NCDS) SUCH AS HEART DISEASE, CANCER, CHRONIC RESPIRATORY DISEASE, AND DIABETES ARE THE LEADING CAUSE OF DEATH...

Read more

NON-COMMUNICABLE DISEASES: SEE SCHEDULE O FOR CONTINUATIONNON-COMMUNICABLE DISEASES (NCDS) SUCH AS HEART DISEASE, CANCER, CHRONIC RESPIRATORY DISEASE, AND DIABETES ARE THE LEADING CAUSE OF DEATH GLOBALLY, EXCEEDING ALL COMMUNICABLE DISEASE DEATHS COMBINED.IN ADDITION TO OUR NCD PROGRAM, WHICH SUPPORTS GOVERNMENTS TO STRENGTHEN AND IMPLEMENT THEIR NCD PREVENTION AND CONTROL STRATEGIES, CHAI IS PARTNERING WITH GOVERNMENTS TO STRENGTHEN CANCER CARE SYSTEMS BY SOLVING CRITICAL SYSTEMIC GAPS. WE BELIEVE BY WORKING IN CLOSE COLLABORATION WITH PARTNER GOVERNMENTS AND BY ANCHORING A SUITE OF TRANSFORMATIONAL INTERVENTIONS, WE CAN DRAMATICALLY IMPROVE SURVIVAL RATES OF CANCER PATIENTS IN LOW- AND MIDDLE-INCOME COUNTRIES. FOR EXAMPLE, OVER THE LAST FOUR YEARS, WE HAVE HELPED SHAPE GLOBAL MARKETS TO RAPIDLY EXPAND ACCESS TO HIGH-QUALITY TOOLS TO SCREEN AND TREAT CERVICAL PRE-CANCER, INCLUDING HUMAN PAPILLOMAVIRUS (HPV) TESTS AND THERMAL ABLATION DEVICES.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Sign In — Free (10 views/day)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $221,270,590
Program Service Revenue $0
Investment Income $3,190,449
Other Revenue $192,261
TOTAL REVENUE $224,653,300

Expense Breakdown

Grants Paid $30,237,599
Salaries & Benefits $113,270,012
Fundraising Expenses $628,618
Program Expenses $209,512,855
Other Expenses $82,084,535
TOTAL EXPENSES $225,603,286

Year-over-Year Comparison

2023 2022 Change
Revenue $224,653,300 $225,088,441 0.0%
Expenses $225,603,286 $225,929,349 0.0%
Net Income $-949,986 $-840,908 +0.1%
Key Indicators
Grants to Organizations Grants to Individuals Lobbying Political Activity Foreign Activities Donor Advised Fund Schedule B Required
🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Sign In

Governance

Voting Members
13
Independent Members
13
Employees
274
Volunteers
43

Governance Policies

Conflict of Interest Policy
Whistleblower Policy
Document Retention Policy

Special Practices & Reported Activities

Operated a School
Operated a Hospital
Provided First Class Travel
Reported Conflict of Interest
Reported Asset Diversion
Excess Benefit Transaction
Made Political Expenditures
Engaged in Lobbying
Operated Donor Advised Fund
Maintained Art Collections
Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers
3
$1,431,438
Total Directors
13
$0
Key Employees
5
$1,444,575
Highest Compensated
5
reported
Name Title Hours/Week Role Reportable Comp Other Comp Total
JOY PHUMAPHI BOARD MEMBER 1.00
Director
$0 $0 $0
ALAN SCHWARTZ BOARD MEMBER 1.00
Director
$0 $0 $0
RAYMOND CHAMBERS BOARD MEMBER 1.00
Director
$0 $0 $0
CHELSEA CLINTON BOARD MEMBER 10.00
Director
$0 $0 $0
WILLIAM J CLINTON BOARD MEMBER 5.00
Director
$0 $0 $0
ALIKO DANGOTE BOARD MEMBER 1.00
Director
$0 $0 $0
OPHELIA DAHL BOARD MEMBER 1.00
Director
$0 $0 $0
DAME SALLY DAVIES BOARD MEMBER 1.00
Director
$0 $0 $0
DR MARK DYBUL BOARD MEMBER 1.00
Director
$0 $0 $0
BRUCE LINDSEY BOARD MEMBER 1.00
Director
$0 $0 $0
LUIS ALBERTO MORENO BOARD MEMBER 1.00
Director
$0 $0 $0
ROBERT W SELANDER BOARD MEMBER 1.00
Director
$0 $0 $0
ANN VENEMAN BOARD MEMBER 1.00
Director
$0 $0 $0
DR NEIL BUDDY SHAH CHIEF EXECUTIVE OFFICER 40.00
Officer
$535,500 $53,797 $589,297
RASHA HIBRI CHIEF FINANCIAL OFFICER 40.00
Officer
$395,352 $61,516 $456,868
ALICE KANG'ETHE CHIEF OPERATING OFFICER(UNTIL 12/23) 40.00
Officer
$355,246 $30,027 $385,273
DR DAVID RIPIN EVP, INFECTIOUS DISEASES/CSO 40.00
Key Emp
$333,354 $54,823 $388,177
DR OWENS WIWA EVP, GLOBAL RESOURCES 40.00
Key Emp
$281,134 $29,959 $311,093
YOUNG JOSHUA CHU EVP, GLOBAL VACCINES & CANCER 40.00
Key Emp
$284,049 $26,310 $310,359
GERALD MACHARIA VP, EAST & SOUTHERN AFRICA/COUNTRY 40.00
Key Emp
$220,379 $20,806 $241,185
DR MPHU RAMATLAPENG EVP, IMPLEMENTATION 40.00
Key Emp
$177,232 $16,529 $193,761
ZACHARY KATZ VP, ESSENTIAL MEDICINES 40.00
Highest
$226,452 $50,099 $276,551
CAROLYN AMOLE HIV/HEPATITIS/TB 40.00
Highest
$217,653 $46,710 $264,363
JUSTIN COHEN GLOBAL MALARIA, NTDS/VECTOR BORN 40.00
Highest
$221,664 $42,795 $264,459
SAMANTHA DIAMOND HEALTH SYSTEMS 40.00
Highest
$190,250 $47,290 $237,540
DANG NGO VP, SOUTHEAST ASIA/PACIFIC 40.00
Highest
$194,448 $22,850 $217,298
Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year Revenue Expenses Assets Net Income
2024 No data No data No data No data
2023 $224,653,300 $225,603,286 $160,736,489 $-949,986
2022 $225,088,441 $225,929,349 $140,374,789 $-840,908
2022 $225,088,441 $225,929,349 $140,374,789 $-840,908
2021 $220,434,799 $217,818,438 $132,736,927 $2,616,361
2020 $198,087,254 $198,671,545 $116,560,796 $-584,291
2019 $190,037,689 $187,496,062 $102,370,576 $2,541,627
2018 $176,278,231 $158,768,452 $105,927,123 $17,509,779
Explore More Nonprofits
Top 100 Nonprofits in Massachusetts Largest U.S. Nonprofits Best Rated Nonprofits Most Efficient Nonprofits

Compare CLINTON HEALTH ACCESS INITIATIVE INC with other nonprofits in Massachusetts and across the country.